青少年血清维生素D水平与非酒精性脂肪性肝病相关性的Meta分析

doi:10.11852/zgetbjzz2024-0122

摘要/Abstract

摘要： 目的系统评价维生素D水平与青少年非酒精性脂肪性肝病(NAFLD)的相关性,为该病的治疗提供新思路。方法检索PubMed、Embase、Cochrane Library、中国知网、万方数据库自2013年1月—2022年12月有关青少年NAFLD与维生素D相关性的文献。通过纽卡斯尔-渥太华量表(NOS)及改编后的NOS量变进行质量评价,采用Stata15.0进行Meta分析。结果共纳入12篇研究,包括922名青少年NAFLD患者。Meta分析显示,NAFLD青少年25(OH)D水平降低(SMD=-1.02,95%CI:-1.54~-0.49,I²=96.9%)。根据研究类型及国家发展程度进行亚组分析,未找到异质性来源,但在各个亚组中NAFLD患者维生素D水平均降低;进行敏感性分析逐一排除各项研究,结果未发生本质改变,提示结果稳定;发表偏倚评价显示未存在明显发表偏倚。结论青少年NAFLD患者维生素D水平降低,维生素D可能参与NAFLD的发展。

关键词: 青少年, 维生素D, 非酒精性脂肪性肝病, Meta分析

Abstract: Objective To systematically evaluate the correlation between vitamin D level and nonalcoholic fatty liver disease (NAFLD) in adolescents, in order to provide new ideas for the treatment of the disease. Methods The literatures regarding the correlation between NAFLD and vitamin D in adolescents from January 2013 to December 2022 were searched in PubMed, Embase, Cochrane Library, China knowledge Network and Wanfang database. Quality of the literature was evaluated by the Newcastle-Ottawa scale (NOS) and the adapted NOS quantitative change, and the Meta-analysis was carried out by Stata15.0. Results A total of 12 studies were included, including 922 adolescent NAFLD patients. Meta-analysis results showed that the level of 25(OH)D in NAFLD adolescents significantly decreased (SMD=-1.02, 95%CI: -1.54 - -0.49, I²=96.9%). The source of heterogeneity was not found in the subgroup analysis on the type of study and the degree of national development,but the vitamin level in each subgroup decreased. Sensitivity analysis excluded each study one by one, and the results did not change in essence, suggesting that the results were stable. No obvious publication bias was found. Conclusion The level of Vitamin D is decreased in adolescent patients with NAFLD, which may be involved in the development of NAFLD.

Key words: adolescent, vitamin D, nonalcoholic fatty liver disease, Meta-analysis

中图分类号:

R725.7

鲁果果, 黄晓金, 李国华, 赵永利. 青少年血清维生素D水平与非酒精性脂肪性肝病相关性的Meta分析[J]. 中国儿童保健杂志, 2024, 32(8): 897-901.

LU Guoguo, HUANG Xiaojin, LI Guohua, ZHAO Yongli. Meta-analysis on the relationship between serum vitamin D level and nonalcoholic fatty liver disease in adolescents[J]. Chinese Journal of Child Health Care, 2024, 32(8): 897-901.

参考文献

[1] Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease—Meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology, 2016,64(1):73-84.
[2] Li J, Ha A, Rui F, et al. Meta-analysis: Global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000-2021[J]. Aliment Pharmacol Ther, 2022,56(3):396-406.
[3] Charoenngam N, Holick MF. Immunologic effects of Vitamin D on human health and disease[J]. Nutrients, 2020,12(7):2097.
[4] Liu J, Song Y, Wang Y, et al. Vitamin D/vitamin D receptor pathway in non-alcoholic fatty liver disease[J]. Expert Opin Ther Targets, 2023,27(11):1145-1157.
[5] Szymczak-Pajor I, Drzewoski J, Sliwinska A. The molecular mechanisms by which vitamin D prevents insulin resistance and associated disorders[J]. Int J Mol Sci, 2020,21(18):6644.
[6] Barchetta I, Cimini FA, Cavallo MG. Vitamin D and metabolic dysfunction-associated fatty liver disease (MAFLD): An update[J]. Nutrients, 2020,12(11):3302.
[7] Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J]. Eur J Epidemiol, 2010,25(9):603-605.
[8] Herzog R, Alvarez-Pasquin MJ, Diaz C, et al. Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review[J]. BMC Public Health, 2013,13:154.
[9] Pirgon O, Cekmez F, Bilgin H, et al. Low 25-hydroxyvitamin D level is associated with insulin sensitivity in obese adolescents with non-alcoholic fatty liver disease[J]. Obes Res Clin Pract, 2013,7(4): e275-e283.
[10] Black LJ, Jacoby P, She PW, et al. Low serum 25-hydroxyvitamin D concentrations associate with non-alcoholic fatty liver disease in adolescents independent of adiposity[J]. J Gastroenterol Hepatol, 2014,29(6):1215-1222.
[11] Malespin M, Sleesman B, Lau A, et al. Prevalence and correlates of suspected nonalcoholic fatty liver disease in Chinese American children[J]. J Clin Gastroenterol, 2015,49(4):345-349.
[12] Mohamed Ahmed A, Abdel Ghany M, Abdel Hakeem GL, et al. Assessment of Vitamin D status in a group of Egyptian children with nonalcoholic fatty liver disease (multicenter study)[J]. Nutr Metab (Lond), 2016,13:53.
[13] Sezer OB, Buluş D, Hızlı Ş, et al. Low 25-hydroxyvitamin D level is not an independent risk factor for hepatosteatosis in obese children[J]. J Pediatr Endocrinol Metab, 2016,29(7):783-788.
[14] 胡颖, 周莹, 何继新, 等. 血清25-羟维生素D3和IL-17水平变化在肥胖儿童非酒精性脂肪肝病进展中的作用[J]. 中国卫生检验杂志, 2018,28(3):323-325.
Hu Y, Zhou Y, He J, et al. Role of changes in serum 25-hydroxyvitamin D3 and IL-17 levels in the progression of nonalcoholic fatty liver disease in obese children [J]. Chinese Journal of Health Inspection, 2018, 28 (3):323-325. (in Chinese)
[15] Cho YH, Kim JW, Shim JO, et al. Association between vitamin D deficiency and suspected nonalcoholic fatty liver disease in an adolescent population[J]. Pediatr Gastroenterol Hepatol Nutr, 2019,22(3):233-241.
[16] 张兰华, 邵琴, 夏振娟. 非酒精性脂肪性肝病儿童血清25-(OH)D₃和IL-17水平变化初步研究[J]. 实用肝脏病杂志, 2019,22(4):522-525.
Zhang L, Shao Q, Xia Z. Preliminary study on changes of serum 25-(OH)D₃ and IL-17 levels in children with nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22 (4):522-525. (in Chinese)
[17] 李婧, 李泽圣, 高成龙, 等. 维生素D与儿童非酒精性脂肪性肝病关系的研究[J]. 国际儿科学杂志, 2020,47(2):141-145.
Li J, Li Z, Gao C, et al. Relationship between vitamin D and nonalcoholic fatty liver disease in children [J]. International Journal of Pediatrics, 2020, 47 (2):141-145. (in Chinese)
[18] Chun LF, Yu EL, Sawh MC, et al. Hepatic steatosis is negatively associated with bone mineral density in children[J]. J Pediatr, 2021,233:105-111.
[19] Yang L, Lin Y, Zhu YF, et al. Controlled attenuation parameter in the diagnosis of different liver steatosis groups in children with obesity[J]. Pediatr Obes, 2022,17(6): e12893.
[20] 杨琳, 林艳, 吴光声. 肥胖儿童非酒精性脂肪性肝炎的相关因素分析[J]. 中华健康管理学杂志, 2022,16(11):776-780.
Yang L, Lin Y, Wu G. Analysis of related factors of nonalcoholic steatohepatitis in obese children[J]. Chinese Journal of Health Management, 2022, 16 (11):776-780. (in Chinese)
[21] Anderson EL, Howe LD, Jones HE, et al. The prevalence of non-alcoholic fatty liver disease in children and adolescents: A systematic review and Meta-analysis[J]. PLoS One, 2015,10(10): e140908.
[22] Zhou J, Zhou F, Wang W, et al. Epidemiological features of NAFLD from 1999 to 2018 in China[J]. Hepatology, 2020,71(5):1851-1864.
[23] Pop TL, Sirbe C, Benta G, et al. The role of vitamin D and vitamin D binding protein in chronic liver diseases[J]. Int J Mol Sci, 2022,23(18):10705.
[24] Cai J, Zhang Z, Liu J, et al. Correlation between serum 25-OH vitamin D expression and non-alcoholic fatty liver disease[J]. Exp Ther Med, 2020,19(3):1681-1686.
[25] Chen LW, Chien CH, Kuo SF, et al. Low vitamin D level was associated with metabolic syndrome and high leptin level in subjects with nonalcoholic fatty liver disease: A community-based study[J]. BMC Gastroenterol, 2019,19(1):126.
[26] Ciardullo S, Muraca E, Cannistraci R, et al. Low 25 (OH) vitamin D levels are associated with increased prevalence of nonalcoholic fatty liver disease and significant liver fibrosis[J]. Diabetes Metab Res Rev, 2023,39(5): e3628.
[27] Roth CL, Elfers CT, Figlewicz DP, et al. Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation[J]. Hepatology, 2012,55(4):1103-1111.
[28] Borges CC, Salles AF, Bringhenti I, et al. Vitamin D deficiency increases lipogenesis and reduces beta-oxidation in the liver of diet-induced obese mice[J]. J Nutr Sci Vitaminol (Tokyo), 2018,64(2):106-115.
[29] Mohd GN, Giribabu N, Salleh N. Mechanisms linking vitamin D deficiency to impaired metabolism: An overview[J]. Int J Endocrinol, 2022,2022:6453882.
[30] Tarfeen N, Nisa KU, Ahmad MB, et al. Metabolic and genetic association of vitamin D with calcium signaling and insulin resistance[J]. Indian J Clin Biochem, 2023,38(4):407-417.
[31] Suk KT, Kim DJ. Gut microbiota: Novel therapeutic target for nonalcoholic fatty liver disease[J]. Expert Rev Gastroenterol Hepatol, 2019,13(3):193-204.
[32] Chen J, Vitetta L. Gut microbiota metabolites in NAFLD pathogenesis and therapeutic implications[J]. Int J Mol Sci, 2020,21(15):5214.
[33] Zeng Y, Luo M, Pan L, et al. Vitamin D signaling maintains intestinal innate immunity and gut microbiota:Potential intervention for metabolic syndrome and NAFLD[J]. Am J Physiol Gastrointest Liver Physiol, 2020,318(3):G542-G553.
[34] Du T, Xiang L, Zhang J, et al. Vitamin D improves hepatic steatosis in NAFLD via regulation of fatty acid uptake and beta-oxidation[J]. Front Endocrinol (Lausanne), 2023,14:1138078.
[35] Li R, Guo E, Yang J, et al. 1,25(OH)₂ D3 attenuates hepatic steatosis by inducing autophagy in mice[J]. Obesity (Silver Spring), 2017,25(3):561-571.
[36] Aggeletopoulou I, Thomopoulos K, Mouzaki A, et al. Vitamin D-VDR novel anti-inflammatory molecules—New insights into their effects on liver diseases[J]. Int J Mol Sci, 2022,23(15).
[37] Mutt SJ, Raza G S, Makinen MJ, et al. Vitamin D deficiency induces insulin resistance and re-supplementation attenuates hepatic glucose output via the PI3K-AKT-FOXO1 mediated pathway[J]. Mol Nutr Food Res, 2020,64(1): e1900728.
[38] Szymczak-Pajor I, S'liwińska A. Analysis of association between vitamin D deficiency and insulin resistance[J]. Nutrients, 2019,11(4):794.
[39] Ma L, Ishigami M, Honda T, et al. Antifibrotic effects of 1,25(OH)₂D3 on nonalcoholic steatohepatitis in female mice[J]. Dig Dis Sci, 2019,64(9):2581-2590.
[40] El Amrousy D, Abdelhai D, Shawky D. Vitamin D and nonalcoholic fatty liver disease in children: A randomized controlled clinical trial[J]. Eur J Pediatr, 2022,181(2):579-586.